Toumaniantz, G.
24  results:
Search for persons X
?
1

High glucose effects on endothelium-dependent vasorelaxatio..:

Hélissen, O. ; Toumaniantz, G. ; Desfontis, J.C..
Archives of Cardiovascular Diseases Supplements.  12 (2020)  2-4 - p. 218 , 2020
 
?
2

DMD TREATMENT: ANIMAL MODELS:

Le Guiner, C. ; Moullier, P. ; McIntyre, M....
Neuromuscular Disorders.  28 (2018)  - p. S93 , 2018
 
?
3

Extensive Characterization of the Newly Developed Dmd mdx R..:

Larcher, T. ; Huchet, C. ; Toumaniantz, G....
Journal of Comparative Pathology.  158 (2018)  - p. 101 , 2018
 
?
4

The SGLT2 inhibitor dapagliflozin prevents cardiomyopathy i..:

Joubert, M. ; Jagu, B. ; Montaigne, D....
Archives of Cardiovascular Diseases Supplements.  9 (2017)  2 - p. 171 , 2017
 
?
 
?
10

277Study of the role of Scn5a in the occurrence of arrhythm..:

Jagu, B ; Le Tourneau, T ; Charpentier, F.
Cardiovascular Research.  103 (2014)  suppl 1 - p. S50.1-S50 , 2014
 
?
12

I025 Smooth muscle specific deletion of the RhoA exchange f..:

Bregeon, J. ; Guilluy, C. ; Toumaniantz, G....
Archives of Cardiovascular Diseases.  102 (2009)  - p. S95-S96 , 2009
 
?
14

Expression of human ERG K channels in the mouse heart exert..:

ROYER, A ; DEMOLOMBE, S ; ELHARCHI, A...
Cardiovascular Research.  65 (2005)  1 - p. 128-137 , 2005
 
?
 
1-15